COVID Associated Mucormycosis –A Clinicoepidemiological Study in a Tertiary Care Centre

Authors

  • Dr. Megha Annigeri, Dr. Laxmi Purushothama, Dr. Lyra Joy, Dr. Annapurna S. Mushannavar Author

DOI:

https://doi.org/10.48047/

Keywords:

antibiotics, covid-19, diabetes, mortality, mucormycosis, steroid

Abstract

Background 
Mucormycosis is a life-threatening opportunistic angioinvasive fungal infection seen in 
immunocompromised states. It’s raise in covid -19 infected individuals was of concern & the entity 
was termed as covid associated mucormycosis (CAM). The disease that was previously present 
endemically was blown to an epidemic. The purpose of this study is to present the epidemiological 
& clinical profile of the cases of CAM that were treated at a tertiary care centre.  

Downloads

Download data is not yet available.

Downloads

Published

2024-12-13

Issue

Vol. 15 No. 12 (2024): volume 15 issue 12 (2024)

Section

Articles